Generic Drug Industry in France Market Research & Statistics

Talk to Sam

+1 718 473 0872

Search inside this page

All regions

You might be interested in: drug, generics, biosimilars, more »

8 reports

Download Unlimited Documents from Trusted Public Sources

Generics Industry in the US and France

  • Actavis Positions itself as a Speciality Pharma Player
  • January 2012
    3 pages
  • Generics  

  • United States  

    France  

    Canada  

View report >

Global Generics Market Share

  • Issn 2229-5054
  • February 2011
    10 pages
  • Generics  

  • Germany  

    United Kingdom  

    Europe  

View report >

Generic Drug Markets - Forecast

  • To Browse this Report Kindly Visit
  • January 2011
    5 pages
  • Generic Drug  

    Generics  

  • United States  

    Europe  

View report >

Generic Drug Statistics in France and the US

  • Brief Reports
  • January 2010
    5 pages
  • Generic Drug  

  • United States  

    France  

View report >

Qpcr Industry in France

  • Journal of Clinical Oncology
  • August 2009
    5 pages
  • Qpcr  

  • France  

View report >

Qpcr Industry in France

  • Journal of Clinical Oncology
  • August 2009
    5 pages
  • Qpcr  

  • France  

View report >

Qpcr Industry in France

  • Journal of Clinical Oncology
  • August 2009
    5 pages
  • Qpcr  

  • France  

View report >

France - Economic Analysis

  • Journal of Clinical Oncology
  • May 2012
    7 pages
  • Generic Drug  

  • France  

View report >
Search in Generic Drug Industry

33 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 175 - $ 1 231)

France Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

France Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: With the aim of improving patient safety and restoring confidence in the country’s drug regulatory process, in December 2011 the French parliament approved ...

Fesoterodine - Patent, Extension And Data Exclusivity ...

July 2014 $ 653

Frovatriptan - Patent, Extension And Data Exclusivity ...

July 2014 $ 653

Galantamine - Patent, Extension And Data Exclusivity E ...

July 2014 $ 653

Ibandronic Acid - Patent, Extension And Data Exclusivi ...

July 2014 $ 653

Imatinib - Patent, Extension And Data Exclusivity Expi ...

July 2014 $ 653

Lasofoxifene - Patent, Extension And Data Exclusivity ...

July 2014 $ 653

Pitavastatin - Patent, Extension And Data Exclusivity ...

July 2014 $ 653

Prasugrel - Patent, Extension And Data Exclusivity Exp ...

July 2014 $ 653

Rizatriptan - Patent, Extension And Data Exclusivity E ...

July 2014 $ 653

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.